Foghorn Therapeutics Inc.
(FHTX)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -98.43M | -108.88M | -101.32M | -68.80M | -51.13M | -26.34M |
| Depreciation & Amortization | 3.45M | 3.32M | 3.23M | 1.33M | 693.00K | 379.00K |
| Stock-Based Compensation | 16.19M | 14.34M | 8.38M | 2.96M | 1.69M | 732.00K |
| Other Working Capital | -42.73M | -20.07M | 336.48M | 28.23M | -14.00K | 1.15M |
| Other Non-Cash Items | 2.56M | 3.29M | 4.61M | 4.44M | 1.20M | 124.00K |
| Deferred Income Tax | - | - | 1.41M | 84.00K | 10.00K | 30.00K |
| Change in Working Capital | -41.88M | 281.55M | 33.44M | 28.70M | 1.20M | 2.42M |
| Operating Cash Flow | -118.11M | 193.61M | -50.25M | -31.29M | -46.34M | -22.65M |
| Capital Expenditures | -1.22M | -1.21M | -3.31M | -16.18M | -968.00K | -1.54M |
| Acquisitions | - | 243.11M | -39.49M | 250.00K | 4.00K | - |
| Purchase of Investments | -73.90M | -409.35M | -99.98M | -92.98M | - | - |
| Sales Maturities Of Investments | 219.57M | 166.23M | 139.47M | -250.00K | - | - |
| Other Investing Acitivies | - | -243.11M | 39.49M | 250.00K | 4.00K | - |
| Investing Cash Flow | 144.45M | -244.32M | 36.17M | -108.91M | -964.00K | -1.54M |
| Debt Repayment | - | - | -21.20M | 4.27M | 7.98M | 11.14M |
| Common Stock Repurchased | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - |
| Other Financial Acitivies | 1.78M | 1.76M | 1.42M | 91.08M | 15.98M | 40.63M |
| Financial Cash Flow | 1.78M | 1.76M | 22.42M | 217.47M | 23.97M | 51.77M |
| Net Cash Flow | 28.12M | -48.95M | 8.34M | 77.27M | -23.33M | 27.58M |
| Free Cash Flow | -119.33M | 192.40M | -53.56M | -47.47M | -47.30M | -24.19M |